Percutaneous mechanical circulatory support has been used to stabilize patients in
cardiogenic shock and provide hemodynamic support during high-risk percutaneous …

See page 49 for disclosure information. List of abbreviations: ACT, activated clotting time;
aPTT, activated partial thromboplastin time; ACHD, adult congenital heart disease; ADHF …

OBJECTIVES: Cardiogenic shock after cardiac surgery is accompanied by a high mortality
rate. Early institution of hemodynamic support with a versatile, easy to insert left ventricular …

Impella LP 5.0 (Abiomed) is a relatively new technology that has been used over the last few
years as a ventricular assist device to provide full circulatory support for patients presenting …

Background Prognosis is poor for patients with decompensated advanced heart failure (HF)
refractory to medical therapy. Evaluating candidacy for durable mechanical circulatory …

Background Acutely decompensated heart failure presents a complicated challenge.
Established temporary support measures have significant adverse effects. A minimally …

Objectives We sought to describe the caliber and vascular health of the subclavian and
axillary arteries as related to their potential utilization in complex cardiovascular procedures …

Background Percutaneous assist devices may be used as a bridge to recovery in patients
with acute myocardial infarction complicated by cardiogenic shock (CS-AMI). Aim To test the …

Abstract OBJECTIVES The Impella 5.0 and 5.5 have largely superseded non-ambulatory
temporary mechanical support devices; yet, clinical outcomes are predominantly limited to …

Introduction Cannabis use is known to be associated with significant cardiovascular
morbidity. We describe three cases of cannabis-related malignant arrhythmias, who …